Average Co-Inventor Count = 5.83
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The United States of America, as Represented by the Secretary, Department of Health and Human Services (14 from 3,540 patents)
2. Mycovia Pharmaceuticals, Inc. (10 from 21 patents)
3. The Brigham and Women's Hospital, Inc. (4 from 1,386 patents)
4. Viamet Pharmaceuticals, Inc. (23 patents)
15 patents:
1. 12286405 - Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase
2. 11654147 - ALK2 inhibitors and methods for inhibiting BMP signaling
3. 11026947 - ALK2 inhibitors and methods for inhibiting BMP signaling
4. 10428025 - Antifungal compound process
5. 10421741 - Antifungal compound process
6. 10407392 - Antifungal compound process
7. 10399943 - Antifungal compound process
8. 10392365 - Antifungal compound process
9. 10173998 - Antifungal compound process
10. 10077250 - Antifungal compound process
11. 10017494 - Antifungal compound process
12. 10017516 - BMP inhibitors and methods of use thereof
13. 10000465 - Antifungal compound process
14. 9981943 - Antifungal compound process
15. 9682983 - BMP inhibitors and methods of use thereof